Boundless Cost Of Revenue from 2010 to 2024

BOLD Stock  USD 9.12  0.57  6.67%   
Boundless Bio,'s Cost Of Revenue is increasing over the years with slightly volatile fluctuation. Cost Of Revenue is expected to dwindle to about 946.4 K. During the period from 2010 to 2024 Boundless Bio, Cost Of Revenue annual values regression line had geometric mean of  728,499 and mean square error of 6.8 B. View All Fundamentals
 
Cost Of Revenue  
First Reported
2010-12-31
Previous Quarter
957 K
Current Value
946.4 K
Quarterly Volatility
110.4 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Boundless Bio, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Boundless main balance sheet or income statement drivers, such as Depreciation And Amortization of 909.1 K, Selling General Administrative of 11.5 M or Other Operating Expenses of 55.2 M, as well as many exotic indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Boundless financial statements analysis is a perfect complement when working with Boundless Bio, Valuation or Volatility modules.
  
This module can also supplement various Boundless Bio, Technical models . Check out the analysis of Boundless Bio, Correlation against competitors.

Latest Boundless Bio,'s Cost Of Revenue Growth Pattern

Below is the plot of the Cost Of Revenue of Boundless Bio, Common over the last few years. Cost of Revenue is found on Boundless Bio, Common income statement and represents the costs associated with goods and services Boundless Bio, provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. It is Boundless Bio,'s Cost Of Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Boundless Bio,'s overall financial position and show how it may be relating to other accounts over time.
Cost Of Revenue10 Years Trend
Slightly volatile
   Cost Of Revenue   
       Timeline  

Boundless Cost Of Revenue Regression Statistics

Arithmetic Mean735,291
Geometric Mean728,499
Coefficient Of Variation15.01
Mean Deviation85,266
Median682,000
Standard Deviation110,362
Sample Variance12.2B
Range275K
R-Value0.69
Mean Square Error6.8B
R-Squared0.48
Significance0
Slope17,145
Total Sum of Squares170.5B

Boundless Cost Of Revenue History

2024946.4 K
2023957 K
2022942 K

About Boundless Bio, Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Boundless Bio, income statement, its balance sheet, and the statement of cash flows. Boundless Bio, investors use historical funamental indicators, such as Boundless Bio,'s Cost Of Revenue, to determine how well the company is positioned to perform in the future. Although Boundless Bio, investors may use each financial statement separately, they are all related. The changes in Boundless Bio,'s assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Boundless Bio,'s income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Boundless Bio, Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Boundless Bio,. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cost Of Revenue957 K946.4 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Boundless Bio, Common is a strong investment it is important to analyze Boundless Bio,'s competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Boundless Bio,'s future performance. For an informed investment choice regarding Boundless Stock, refer to the following important reports:
Check out the analysis of Boundless Bio, Correlation against competitors.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Complementary Tools for Boundless Stock analysis

When running Boundless Bio,'s price analysis, check to measure Boundless Bio,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boundless Bio, is operating at the current time. Most of Boundless Bio,'s value examination focuses on studying past and present price action to predict the probability of Boundless Bio,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boundless Bio,'s price. Additionally, you may evaluate how the addition of Boundless Bio, to your portfolios can decrease your overall portfolio volatility.
Commodity Directory
Find actively traded commodities issued by global exchanges
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Stocks Directory
Find actively traded stocks across global markets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Is Boundless Bio,'s industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Boundless Bio,. If investors know Boundless will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Boundless Bio, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Return On Assets
(0.33)
Return On Equity
(0.53)
The market value of Boundless Bio, Common is measured differently than its book value, which is the value of Boundless that is recorded on the company's balance sheet. Investors also form their own opinion of Boundless Bio,'s value that differs from its market value or its book value, called intrinsic value, which is Boundless Bio,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Boundless Bio,'s market value can be influenced by many factors that don't directly affect Boundless Bio,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Boundless Bio,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Boundless Bio, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Boundless Bio,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.